AMGEN INC is 60.5x more valuable than Beam Therapeutics Inc. by market capitalization ($183.41 B vs $3.03 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | BEAM | AMGN |
|---|---|---|
| Market cap | $3.03 B | $183.41 B |
| US-listed rank | #1789 | #79 |
| Revenue (latest FY) | $139.74M | $36.75B |
| Net income (latest FY) | -$79.99M | $7.71B |
| Net margin | -57.2% | 21.0% |
| P/E (trailing FY) | - | 23.8 |
| SEC filings | 488 | 1,011 |
AMGEN INC is 60.5x more valuable than Beam Therapeutics Inc. by market capitalization ($183.41 B vs $3.03 B).
In their latest fiscal years, Beam Therapeutics Inc. reported $139.74M in revenue while AMGEN INC reported $36.75B.
Full pages: Beam Therapeutics Inc. and AMGEN INC, or browse the full rankings.